Topolog
View all posts »Symplicity: A key to treating severe resistant hypertension
Dec 3, 2010 11:20 EST-
2Comments
-
Read later
Impressive results from the Symplicity HTN-2 trial, which sought to treat severe resistant hypertension with renal nerve denervation, point to a new mainstay of therapy and pose a number of stimulating questions: Who will perform this operation? How much will it cost? Can the (partially blind) procedure be tweaked and improved? Might treatment also be appropriate for patients with milder hypertension?
What are your thoughts on renal denervation to treat hypertension?
See:
A revolutionary road for resistant hypertension? Renal denervation in Symplicity HTN-2
Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010. Published Online: 17 November 2010. Abstract.
|
||||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!













